EIP
EDIT icon

Essential Investment Partners’s Editas Medicine EDIT Stock Holding History

Essential Investment Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65 Hold
20
– – ﹤0.01% 308
2026
Q1 		$49 Hold
20
– – ﹤0.01% 298
2025
Q4 		$41 Buy
+20
New +$58 ﹤0.01% 283

Other funds holding EDIT

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TWM
Thrive Wealth Management Audubon, Pennsylvania $787M AUM 23.6% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
DIM
DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Essential Investment Partners's EDIT Position: Q2 2026 in Review

Essential Investment Partners held its Editas Medicine (EDIT) position steady in Q2 2026 at 20 shares worth $65. The position accounts for ﹤0.01% of the portfolio, ranked #308.

Essential Investment Partners first reported a position in EDIT in Q4 2025 and has held it in 3 quarters since. 27 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Essential Investment Partners held 20 shares of Editas Medicine worth $65 as of Q2 2026.
  • Essential Investment Partners left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Essential Investment Partners's portfolio in Q2 2026, its #308 holding.
  • Essential Investment Partners first reported a position in Editas Medicine in Q4 2025 and has held it in 3 quarters since.
  • 27 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Essential Investment Partners's 13F filing for Q2 2026, filed 15 Jul 2026.